Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline for knee osteoarthritis pain
ACTRN12614000683639Phase 3Completed
- Sponsor
- Dr Ben Hudson
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nortriptyline in osteoarthritis (OA), sponsored by Dr Ben Hudson. Primary endpoint: Mean pain score difference at 14 weeks. Started Mar 2015; status: completed.
02
Drugs
nortriptyline
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12614000683639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000683639.